Abattis Subsidiary, Northern Vine, Provides Update on Growth Targets (PR)

1 Response Abattis News | Northern Vine | Raybot

VANCOUVER, British Columbia / GLOBE NEWSWIRE / Aug. 23, 2017 Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to provide an update on its subsidiary, Northern Vine Canada Inc. (“Northern Vine”), which specializes in the legal testing and analysis of cannabis products and is expected to soon commence extraction of cannabinoid derivatives […]

Abattis Provides Company Update (PR)

0 Responses Abattis News | Northern Vine | Raybot | Vergence

Vancouver, British Columbia / Newsfile Corp. / June 13, 2017 Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the “Company” or “Abattis“) is pleased to provide an update of recent developments and achievements. Testing Revenues at Northern Vine Labs Since the launch of its first lab in May of 2017, the Company’s subsidiary, Northern Vine Canada […]

Abattis: Northern Vine Labs Expands Its Sales Team (PR)

5 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / May 10, 2017 Abattis Bioceuticals Corp. (CSE:ATT) (ATTBF) (the “Company” or “Abattis“) is pleased to announce the addition of Siobhan McCarthy as Sales & Marketing Manager for the Company’s subsidiary Northern Vine Canada Inc. (“Northern Vine“). Ms. McCarthy brings more than 20 years of direct sales and marketing experience to […]

Abattis Announces the Official Launch of Northern Vine Laboratory (PR)

6 Responses Abattis News | Health Canada | Northern Vine | Raybot

Vancouver, British Columbia / Newsfile Corp / May 3, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) is pleased to announce that its subsidiary, Northern Vine Canada Inc. (“Northern Vine“), has officially launched its flagship laboratory, having completed its first successful test analysis. “I am very pleased to announce this significant […]

Abattis Signs Exclusive Distribution Agreement for Proprietary Extraction Technology (PR)

16 Responses Abattis News | Health Canada | Northern Vine | Raybot

VANCOUVER, BC / ACCESSWIRE / April 26, 2017 Abattis Bioceuticals Corp. (CSE:ATT) (ATTBF) (the “Company” or “Abattis“) is pleased to announce that it has signed an exclusive distribution agreement, effective April 20, 2017 (the “Agreement“), with Suzhou Raybot Material Tech Corp. (“Raybot“). The Agreement allows Abattis to use Raybot’s proprietary extraction technology and to exclusively […]

Northern Vine Labs Officially Listed as a Licensed Laboratory to Test Cannabis

24 Responses Health Canada | Northern Vine

Abattis Bioceutical Corp’s (OTC: ATTBF, CSE: ATT) Northern Vine Labs finally has its name shining bright on the canada.ca “Laboratories licensed to conduct activities with cannabis” page. Previously, the page had not been updated since September 2, 2016, and Northern Vine Labs had acquired it’s license on the 16th of the same month. This was […]

Please Add Northern Vine Labs to Canada’s Licensed Laboratory List

8 Responses Health Canada | Northern Vine

Today I am reaching out to all industry followers – especially Abattis Bioceuticals enthusiasts and investors – to help put an end to some confusion. Researchers looking to the Government of Canada’s (canada.ca) website for a full list of laboratories licensed to conduct activities with cannabis would be expecting to see Abattis’ Northern Vine Labs […]

Demand for Northern Vine Lab Services – Evidence from the Task Force on Cannabis Legalization and Regulation

4 Responses Health Canada | Northern Vine

Abattis Bioceuticals Corp’s subsidiary, Northern Vine Labs, received a Controlled Substance license from Health Canada in October 3, 2016. This allows Northern Vine to provide analytical testing of cannabis products to licensed producers in Canada. Many Abattis followers were estatic about the news when it first surfaced. Yes – it’s certainly easy to view the […]

Abattis Bioceuticals Announces New CEO

5 Responses Abattis News | Management | Northern Vine

VANCOUVER, BC / ACCESSWIRE / April 10, 2017 Abattis Bioceuticals Corp. (CSE:ATT) (ATTBF) (the “Company” or “Abattis”) is pleased to announce the appointment of Robert Abenante as President and Chief Executive Officer of the Company. Mr. Abenante is a seasoned executive with extensive public company experience. Mr. Abenante is a Chartered Professional Accountant (CPA, CA) […]

Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC (PR)

3 Responses Abattis News | Marijuana Investment | Northern Vine

VANCOUVER, BC / ACCESSWIRE / April 6, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), is pleased to announce it has officially been added to The Marijuana Index, within the Biotechnology sector. The North American Marijuana Index tracks the leading public cannabis companies operating in the United States and Canada and gives investors […]

Abattis.club: Discussion Portal for Abattis Bioceuticals Corp and General Marijuana Industry

16 Responses Health Canada | Northern Vine | Site Announcements

If you’re reading this, I realize it may very well be your first time coming across Abattis.club. If that’s the case – Welcome! We’re glad you’re here. Let me walk you through what this place is all about. What’s the Big Deal About Marijuana in Canada? In late 2013, me and some colleagues stumbled upon […]

Canada’s Plans for Near-term Legalization Puts Testing into Focus (CFN Media)

0 Responses Abattis News | Northern Vine

SEATTLE, WA / Marketwired / Apr 4, 2017 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing the planned legalization of cannabis in Canada, the growing and urgent need for testing in both the existing and upcoming legal cannabis markets, and Abattis […]

Abattis: Legislation to Legalize Marijuana in Canada is Being Announced Next Month (PR)

0 Responses Abattis News | Health Canada | Northern Vine

VANCOUVER, BC / ACCESSWIRE / March 27, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), and its subsidiary, Northern Vine Labs, is anticipating the Liberal government’s upcoming announcement, next month (the week of April 10th), on legislation that will legalize recreational marijuana use across Canada by July 1, 2018. As reported by the […]

Abattis Welcomes Dr. David Galvez as Science Advisor to Northern Vine (PR)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / March 20, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce that Dr. David Galvez, PhD, will be joining the team to lead Northern Vine’s Science Advisory efforts. Dr. Galvez received his doctorate in Plant Physiology at the University of Alberta and is a seasoned […]

Abattis Team Positions for Next Stage of Growth (PR)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / March 13, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce the addition of Jaclyn Thomson, PhD, to our senior management team at Northern Vine Labs, and the appointment of Rene David to the Abattis Board of Directors. As the construction and buildout of Northern […]

Abattis Completes Audit and Prepares to Launch Northern Vine Labs (PR)

0 Responses Abattis News | Health Canada | Northern Vine

VANCOUVER, BC / ACCESSWIRE / February 24, 2017 Abattis Bioceuticals Corp. (ATTBF) (CNSX:ATT) (“ATT” or the “Company”) is pleased to announce the completion of their annual audit. The delay in filing was due to an eventful year with new programs coming online and an aggressive strategy to cut non-core assets resulting in prolonged consolidations and […]

Abattis Explores Diversifying with a Strategic Acquisition (CFN Media)

0 Responses Abattis News | Northern Vine

SEATTLE, WA / Marketwired / Jan 19, 2017 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. ( OTC PINK : ATTBF ) ( CNSX : ATT ), a specialty agricultural technology firm focused on the legal cannabis industry. […]

Abattis Bioceuticals (ATTBF) Northern Vine Labs and the New Canadian Rules (CFN Media)

0 Responses Abattis News | Health Canada | Northern Vine

SEATTLE, WA / Marketwired / Jan 5, 2017 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Abattis Bioceuticals Corp.’s ( OTCQB : ATTBF ) ( CSE : ATT ) Northern Vine Labs subsidiary and the effect newly proposed rules in Canada […]

Abattis Provides Corporate Update (PR: 12/16/16)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / December 16, 2016 Abattis Bioceuticals Corp. (ATTBF) (CNSX:ATT) (the “Company” or “Abattis”) provides an update to its shareholder. CEO Rene David provides an update to shareholders after reviewing the latest report from the Canadian Cannabis Task Force on Legalization and Regulation. “After having a chance to review the report, we are even […]

Abattis Announces the Appointment of New Independent Director (PR)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / November 2, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), announces the appointment of Dr. William Panenka to the Board of Directors. Dr. Panenka received his M.D. and M.Sc. from the University of Calgary in Canada. His M.Sc was basic science-focused utilizing Western Blotting, PCR, in-situ hybridization and […]

Abattis’ Federally Licensed Lab and the Crucial Role It Plays (CFN Media)

0 Responses Abattis News | Northern Vine

SEATTLE, WA / Marketwired / Nov 2, 2016 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals ( OTCQB : ATTBF ) ( CSE : ATT ). The company recently announced the receipt of a Controlled Substance License from Health […]

Abattis Bioceuticals Corp: Experion Biotechnologies Prepares for Construction (PR)

0 Responses Abattis News | Experion | Northern Vine

VANCOUVER, BC / ACCESSWIRE / October 17, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), announces commencement of construction for the Experion secure, production facility. Experion Biotechnologies Inc. is pleased to announce that it has begun the construction process and prepares to break ground for the six-month build-out for its 8,000 square foot, […]